Today: 21 March 2026
Subscribe
Browse Category

Stock Market 13 January 2026

Ofwat warns on South East Water outage as Severn Trent, United Utilities shares fall

Ofwat warns on South East Water outage as Severn Trent, United Utilities shares fall

Around 25,000 homes in Kent and Sussex lost water after a new supply failure at South East Water, prompting Ofwat to flag concern and launch a review. Shares in Severn Trent, United Utilities, and Pennon fell up to 2.6% as scrutiny intensified. South East Water is using tankers and bottled-water stations while restoring pressure, with full service expected by Wednesday. Some homes have faced four days without water.
13 January 2026
···
AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie stock nudges lower after Trump drug-price pact; traders watch JPM talk, Feb. 4 results

AbbVie shares fell 0.1% to $219.83 Tuesday after announcing a three-year U.S. pricing deal tied to tariff exemptions. The company also signed a $650 million licensing agreement with China’s RemeGen for rights to an experimental cancer drug and bought a manufacturing site in Arizona. Management is set to speak at the J.P. Morgan Healthcare Conference on Jan. 14.
13 January 2026
··
Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam stock dips as Amvuttra sales miss some forecasts; 2026 outlook in focus

Alnylam shares fell 0.1% to $370.39 Tuesday afternoon after the company projected 2026 net product revenue between $4.9 billion and $5.3 billion. Preliminary 2025 sales were disclosed at $2.987 billion. Analysts remained mostly positive but flagged possible weakness for Amvuttra next quarter. The update came as Alnylam outlined its new five-year strategy at the J.P. Morgan Healthcare Conference.
13 January 2026
··
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals shares fell 10.6% after the FDA extended its review of partner Travere’s Filspari label expansion, resetting the decision deadline to April 13. Travere shares dropped 19%. The FDA classified the latest filing as a “major amendment” but did not request new safety or manufacturing data. The broader biotech sector was little changed.
13 January 2026
···
Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola shares rose 0.5% to $70.83 Tuesday after the company set Feb. 10 for its Q4 and full-year earnings release and investor call. CEO-elect Henrique Braun and CFO John Murphy will speak at the CAGNY conference in Orlando on Feb. 17. Coke expects a $1 billion impairment charge in Q4 tied to its Africa bottling sale. PepsiCo shares gained 1.4% while the S&P 500 ETF slipped 0.4%.
13 January 2026
··
American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines shares fell 3.5% to $15.44 Tuesday, underperforming other major U.S. carriers as investors reacted to Delta’s profit forecast and concerns over a proposed 10% cap on credit-card interest rates. The cap could threaten airline loyalty program profits. American will report earnings Jan. 27, the same day the NTSB holds a hearing on a 2025 fatal crash involving one of its regional jets.
13 January 2026
·····
Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Travere Therapeutics shares fell 19% Tuesday after the FDA extended its review of Filspari for broader use in kidney disease, pushing the decision deadline to April 13. The stock hit an intraday low of $22.35 before recovering. Travere forecast $127 million in Q4 U.S. net product sales and ended 2025 with $323 million in cash and equivalents. Analyst Joseph Schwartz warned a formal rejection from the FDA remains possible.
13 January 2026
··
Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol shares rose 2.2% to $148.28 Tuesday, bucking a broader market decline after finalizing its $10.5 billion acquisition of CommScope’s CCS business. Analysts at Barclays, Citi, and Truist raised price targets, citing expected sales growth and stronger demand. The company projects CCS will add $4.1 billion in 2026 sales and $0.15 to EPS, excluding costs. Quarterly earnings are due Jan. 28.
13 January 2026
···
Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo shares fell 1.6% to $93.44 Tuesday, ahead of its fourth-quarter earnings release set for 7 a.m. ET Wednesday. The drop followed President Trump’s proposal for a 10% cap on credit card interest rates, which hit bank stocks. Trading volume reached 11.4 million shares. Investors are watching credit costs and margins amid policy uncertainty and fresh inflation data.
13 January 2026
··
Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital shares rose 1.6% to $215.57 on Tuesday, ahead of its fiscal Q2 results set for Jan. 29 after the market closes. The stock has swung sharply in recent sessions, fueled by AI-driven demand for storage and recent bullish comments from Nvidia’s CEO. Analysts expect quarterly EPS of $1.92 and revenue near $2.91 billion. Seagate also gained, while Micron fell 2.3%.
13 January 2026
····
Chevron stock climbs as oil jumps, but drones and a Jan. 17 deadline keep CVX traders on edge

Chevron stock climbs as oil jumps, but drones and a Jan. 17 deadline keep CVX traders on edge

Chevron shares rose 2.2% to $165.95 Tuesday after drones struck two Black Sea tankers, including one chartered by the company. Crude prices jumped as unrest in Iran fueled supply fears, with Brent up 2.5% to $65.44 a barrel. Chevron confirmed all crew are safe. War-risk insurance premiums for Black Sea shipping nearly doubled following the attacks.
13 January 2026
·····
Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus Corp (PLXS) shares surged about 7% to $171.65 Tuesday, outpacing peers in a broad electronics manufacturing rally. The move followed a December inflation report showing consumer prices up 2.7% year-on-year. Analysts expect Plexus to report Q1 EPS near $1.77 on January 28. The stock now trades above the average analyst target of $159.
13 January 2026
····
Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Bitcoin rose 2.2% to $93,478 Tuesday, with Coinbase up 3% and Strategy gaining 4.2% after disclosing a $1.25 billion bitcoin purchase. U.S.-listed spot bitcoin ETFs advanced about 2.3%. Senators late Monday released draft legislation to clarify crypto rules, granting the CFTC more oversight. December CPI rose 0.3%, keeping annual inflation at 2.7% ahead of the Jan. 27-28 Fed meeting.
13 January 2026
·······
Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin shares rose about 1% Tuesday, peaking at $564. Jefferies raised its price target to $540 but kept a Hold rating, citing possible weakness in 2026 guidance. Lockheed delivered its 350th MH-60R helicopter to the U.S. Navy and hosted Secretary of War Pete Hegseth at its F-35 plant. Investors await fourth-quarter results on Jan. 29 for details on 2026 margins and production.
13 January 2026
···
1 … 515 516 517 518 519 … 1,358

Stock Market Today

  • Diageo Considers Guinness Spin Off Amid Portfolio Shift and Pricing Changes
    March 21, 2026, 12:33 PM EDT. Diageo (LSE:DGE) is reportedly exploring a spin off of its Guinness brand following weak financial results and shifting consumer demand towards lower-priced spirits. The move reflects a strategic reassessment of how Guinness fits within Diageo's portfolio, which includes Scotch, tequila, and vodka. Concurrently, the company is pursuing new brand partnerships and limited product launches, such as the IDL partnership for CÎROC Ultra Premium Vodka and a limited Oban 15 Year Old Port Cask Finish, aiming to maintain premium appeal despite consumer trends favoring value options. A Guinness spin off would reshape Diageo's capital allocation and portfolio balance, potentially leaving a more spirits-heavy mix to justify marketing investments. Investors should watch how these changes impact the balance between premium and value offerings, as well as future cash flow resilience.
Go toTop